These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 33185709)

  • 21. Progress Toward Regional Measles Elimination - Worldwide, 2000-2015.
    Patel MK; Gacic-Dobo M; Strebel PM; Dabbagh A; Mulders MN; Okwo-Bele JM; Dumolard L; Rota PA; Kretsinger K; Goodson JL
    MMWR Morb Mortal Wkly Rep; 2016 Nov; 65(44):1228-1233. PubMed ID: 27832050
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Closer to the goal: efforts in measles elimination in Germany 2010.
    Siedler A; Mankertz A; Feil F; Ahlemeyer G; Hornig A; Kirchner M; Beyrer K; Dreesman J; Scharkus S; Marcic A; Reiter S; Matysiak-Klose D; Santibanez S; Krause G; Wichmann O
    J Infect Dis; 2011 Jul; 204 Suppl 1():S373-80. PubMed ID: 21666187
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prospects for the eradication of infectious diseases.
    Stuart-Harris C
    Rev Infect Dis; 1984; 6(3):405-11. PubMed ID: 6377445
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Measles control in developing and developed countries: the case for a two-dose policy.
    Tulchinsky TH; Ginsberg GM; Abed Y; Angeles MT; Akukwe C; Bonn J
    Bull World Health Organ; 1993; 71(1):93-103. PubMed ID: 8440043
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Measles in Germany: An Epidemiological Analysis and First Measures for Containment].
    Matysiak-Klose D; Wicker S;
    Dtsch Med Wochenschr; 2017 Nov; 142(23):1767-1772. PubMed ID: 29145682
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of measles supplementary immunization activities on reaching children missed by routine programs.
    Portnoy A; Jit M; Helleringer S; Verguet S
    Vaccine; 2018 Jan; 36(1):170-178. PubMed ID: 29174680
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Measles and Rubella Global Strategic Plan 2012-2020 midterm review report: Background and summary.
    Orenstein WA; Cairns L; Hinman A; Nkowane B; Olivé JM; Reingold AL
    Vaccine; 2018 Jan; 36 Suppl 1():A35-A42. PubMed ID: 29307368
    [TBL] [Abstract][Full Text] [Related]  

  • 28. First 5 years of measles elimination in southern Africa: 1996-2000.
    Biellik R; Madema S; Taole A; Kutsulukuta A; Allies E; Eggers R; Ngcobo N; Nxumalo M; Shearley A; Mabuzane E; Kufa E; Okwo-Bele JM
    Lancet; 2002 May; 359(9317):1564-8. PubMed ID: 12047966
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effectiveness, population-level effects, and heath economics of measles and rubella vaccination].
    Wichmann O; Ultsch B
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2013 Sep; 56(9):1260-9. PubMed ID: 23990088
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Determinants of low measles vaccination coverage in children living in an endemic area.
    Lo Vecchio A; Cambriglia MD; Fedele MC; Basile FW; Chiatto F; Miraglia Del Giudice M; Guarino A
    Eur J Pediatr; 2019 Feb; 178(2):243-251. PubMed ID: 30430239
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Progress Toward Regional Measles Elimination - Worldwide, 2000-2018.
    Patel MK; Dumolard L; Nedelec Y; Sodha SV; Steulet C; Gacic-Dobo M; Kretsinger K; McFarland J; Rota PA; Goodson JL
    MMWR Morb Mortal Wkly Rep; 2019 Dec; 68(48):1105-1111. PubMed ID: 31805033
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recommendations from meeting on strategies for improving global measles control, May 11-12, 2000.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2000 Dec; 49(49):1116-8. PubMed ID: 11917928
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Measles vaccination in an increasingly immunized and developed world.
    Hayman DTS
    Hum Vaccin Immunother; 2019; 15(1):28-33. PubMed ID: 30156949
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Hot spot: epidemiology of measles and rubella in Germany and the WHO European region].
    Matysiak-Klose D
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2013 Sep; 56(9):1231-7. PubMed ID: 23990084
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A review of measles control in Kenya, with focus on recent innovations.
    Manakongtreecheep K; Davis R
    Pan Afr Med J; 2017; 27(Suppl 3):15. PubMed ID: 29296150
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Progress toward measles elimination in Germany.
    Hellenbrand W; Siedler A; Tischer A; Meyer C; Reiter S; Rasch G; Teichmann D; Santibanez S; Altmann D; Claus H; Kramer M
    J Infect Dis; 2003 May; 187 Suppl 1():S208-16. PubMed ID: 12721915
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Progress toward measles elimination--Southern Africa, 1996-1998.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1999 Jul; 48(27):585-9. PubMed ID: 10428097
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regional reports for the subnational monitoring of measles elimination in Italy and the identification of local barriers to the attainment of the elimination goal.
    Adamo G; Sturabotti G; Baccolini V; de Soccio P; Prencipe GP; Bella A; Magurano F; Iannazzo S; Villari P; Marzuillo C
    PLoS One; 2018; 13(10):e0205147. PubMed ID: 30356247
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Progress toward regional measles elimination - worldwide, 2000-2014.
    Perry RT; Murray JS; Gacic-Dobo M; Dabbagh A; Mulders MN; Strebel PM; Okwo-Bele JM; Rota PA; Goodson JL
    MMWR Morb Mortal Wkly Rep; 2015 Nov; 64(44):1246-51. PubMed ID: 26562349
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.